PRKN and osteosarcoma: Future research needs to further investigate the functions and regulatory mechanisms of E3 ubiquitin ligases in osteosarcoma, particularly their interactions and coordinated regulation with other signaling pathways, and verify their efficacy and safety in clinical treatment.